San Diego-primarily based Viking Therapeutics marked alone as a significant competitor during the weight loss drug market place in February right after revealing promising facts from the mid-stage trial of experimental drug VK2735, which proposed it rivaled—and outperformed—Novo and Lilly drugs when supplied to be a weekly injection and in Marc